Quick Search Form

Book Title: Treating and Preventing Adolescent Mental Health Disorders  > pp. [679]
Click here to open a preview window containing the current page in a printer-friendly form Printer Friendly   go to page    previous  |  next

 
Dougherty, D. D., Rauch, S. L., & Jenike, M. A. (2002). Pharmacological treatments for obsessive compulsive disorder. In P. E. Nathan & J. M. Gorman (Eds.), A guide to treatments that work (2nd ed.) London: Oxford University Press.
Eaves, L. J., Eysenck, H. J., & Martin M. (1989). Genes, culture and personality; An empirical approach. New York: Academic Press.
Eaves, L. J., Silberg, J. L., Maes, H. H., Simonoff, E., Pickles, A., Rutter, M., et al. (1997). Genetics and developmental psychopathology: The main effects of genes and environment on behavioral problems in the Virginia Twin Study of adolescent behavior development. Journal of Child Psychology and Psychiatry and Allied Disciplines, 38, 965–980.
Echeburua, E., de Corral, P., Zubizarreta, I., & Sarsua, B. (1997). Psychological treatment of chronic posttraumatic stress disorder in victims of sexual aggression. Behavior Modification, 21, 433–456.
Emslie, G. J., Rush, A. J., Weinberg, W. A., Kowatch, R. A., Hughes, C. W., Carmody, T., et al. (1997). A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry, 54, 1031–1037.
Fairbanks, J. M., Pine, D. S., Tancer, N. K., Dummit E. S., III, Kentgen, L. M., Asche, B. K., et al. (1997). Open fluoxetine treatment of mixed anxiety disorders in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 7, 17–29.
Famularo, R., Spivak, G., Bunshaft, D., & Berkson, J. (1988). Advisability of substance abuse testing in parents who severely maltreat their children: The issue of drug testing before the juvenile/family courts. Bulletin of the American Academy of Psychiatry and the Law, 16, 217–223.
Fitzgerald, K. D., Stewart, C. M., Tawile, V., & Rosenberg, D. R. (1999). Risperidone augmentation of serotonin reuptake inhibitor treatment
end p.679
  go to page    previous  |  next

 
-->
Contents
 
scroll up fast
scroll up
 
scroll down
scroll down fast

Return to Top